Aaron Diamond AIDS Research Center (ADARC)
Search All News
Columbia researchers have isolated antibodies from COVID-19 patients that neutralize SARS-CoV-2 virus and could be used to treat patients or prevent infections.
Dr. Ho is leading four research teams at Columbia University to identify antivirals as well as monoclonal neutralizing antibodies that may be used to treat and prevent infection with SARS-CoV-2.
Source:NBC New York
In an interview with NBC News, Dr. David Ho answers questions about the seriousness of the emerging pandemic.
Dr. David Ho had a Q&A with members of the Caltech community to discuss the novel coronavirus and the future of our society in the light of this global pandemic.
Source:TimeFebruary 26, 2020
Dr. David Ho has secured funding from China’s richest man to lead a team of researchers at Columbia University to combat the newly emerging pandemic.
Source:Columbia University Irving Medical CenterFebruary 20, 2020
According to a release four research teams will share a $2.1 million grant to mount an aggressive effort to identify potential drugs and antibodies for use against the new coronavirus, 2019-nCoV.
Source:China DailyFebruary 10, 2020
Dr. David Ho discussed the challenges of treating the novel Coronavirus pneumonia (NCP) and the need to rapidly identify the exist antivirals for HIV infection to fight against the new Coronavirus.
Source:China DailyFebruary 2, 2020
Dr. David Ho discussed the challenges of treating the novel Coronavirus pneumonia and existing antivirals that have been used for HIV infection that may have activity against the new Coronavirus.